Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses

From MaRDI portal
Publication:5715359

DOI10.1111/j.0006-341X.2005.031002.xzbMath1077.62064WikidataQ52974017 ScholiaQ52974017MaRDI QIDQ5715359

Atanu Biswas, Anthony C. Atkinson

Publication date: 3 January 2006

Published in: Biometrics (Search for Journal in Brave)




Related Items

A simple solution to the inadequacy of asymptotic likelihood-based inference for response-adaptive clinical trials: likelihood-based inference for RAR trials, A new inferential approach for response-adaptive clinical trials: the variance-stabilized bootstrap, Asymptotic properties of covariate-adjusted response-adaptive designs, A new design strategy for hypothesis testing under response adaptive randomization, Optimal response and covariate-adaptive biased-coin designs for clinical trials with continuous multivariate or longitudinal responses, Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides, A new response-adaptive design for continuous treatment responses for phase III clinical trials, A numerical study for comparing two response-adaptive designs for continuous treatment effects, Handling covariates in the design of clinical trials, A sequential design for a clinical trial with a linear prognostic factor, Fixed-width confidence interval for covariate-adjusted response-adaptive designs, Bayesian doubly adaptive randomization in clinical trials, Predictability of designs which adjust for imbalances in prognostic factors, Adaptive two‐treatment two‐period crossover design for binary treatment responses, A general adaptive allocation design for continuous responses in the presence of covariates, Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang, Multi-treatment optimal response-adaptive designs for phase III clinical trials, A Bayesian adaptive design for two-stage clinical trials with survival data, Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint, Contribution of Milton Sobel in Selection Problem Following Ethical Allocation, Kernel-Based Response-Adaptive Design for Continuous Responses, Unnamed Item, Selecting a biased-coin design



Cites Work